UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
SCHEDULE
13G
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT
NO. __)
OWC
Pharmaceutical Research Corp.
(Name
of Issuer)
Common
Stock
(Title
of Class of Securities)
26784V108
(CUSIP
Number)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐
Rule 13d-1(c)
☐
Rule 13d-1(d)
*The
remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover
page.
The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18
of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).
1.
NAMES OF REPORTING PERSON
DISCOVER
GROWTH FUND, LLC
S.S.
OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
66-0854607
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a)
☐
(b)
☐
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
VIRGIN ISLANDS
5.
SOLE VOTING POWER, NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON –
55,493,834
6.
SHARED VOTING POWER -
0
7.
SOLE DISPOSITIVE POWER –
55,493,834
8.
SHARED DISPOSITIVE POWER -
0
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -
55,493,834
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.99%
12.
TYPE OF REPORTING PERSON
OO
ITEM
1 (a) NAME OF ISSUER:
OWC
Pharmaceutical Research Corp.
ITEM
1 (b) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:
2
Ben Gurion Street, Ramat Gan, Israel 4514760
ITEM
2 (a) NAME OF PERSON FILING:
Discover
Growth Fund, LLC
ITEM
2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
5330
Yacht Haven Grande, Suite 206, St. Thomas, VI 00802
ITEM
2 (c) CITIZENSHIP:
U.S.
Virgin Islands
ITEM
2 (d) TITLE OF CLASS OF SECURITIES:
Common
Stock
ITEM
2 (e) CUSIP NUMBER:
26784V108
ITEM
3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A:
(a)
|
☐
|
Broker
or dealer registered under Section 15 of the Exchange Act.
|
(b)
|
☐
|
Bank
as defined in Section 3(a)(6) of the Exchange Act.
|
(c)
|
☐
|
Insurance
Company defined in Section 3(a)(19) of the Exchange Act.
|
(d)
|
☐
|
Investment
Company registered under Section 8 of the Investment Company Act.
|
(e)
|
☐
|
An
Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E)
|
(f)
|
☐
|
An
employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(ii)(F)
|
(g)
|
☐
|
A
parent holding company or control person in accordance Rule 13d-1(b)(1)(ii)(G)
|
(h)
|
☐
|
A
savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
|
(i)
|
☐
|
A
church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
|
(j)
|
☐
|
Group,
in accordance with Rule 13d-1(b)(1)(ii)(J)
|
ITEM
4 OWNERSHIP
(a)
AMOUNT BENEFICIALLY OWNED: 55,493,834
(b)
PERCENT OF CLASS: 9.99%
(c)
NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i)
SOLE POWER TO VOTE OR DIRECT THE VOTE 55,493,834
(ii)
SHARED POWER TO VOTE OR DIRECT THE VOTE 0
(iii)
SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF 55,493,834
(iv)
SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF 0
The
Reporting Person holds 366 shares of Series A Redeemable Convertible Preferred Stock, which are convertible into shares of Common Stock
of the issuer; provided that the issuer may not issue shares which, when aggregated with all other shares of Common Stock then deemed
beneficially owned by the reporting person, would result in the Reporting Person holding at any one time more than 9.99% of all Common
Stock outstanding immediately after giving effect to such issuance.
ITEM
5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
ITEM
6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
ITEM
7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
ITEM
8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP
ITEM
9 NOTICE OF DISSOLUTION OF GROUP
ITEM
10. CERTIFICATION.
By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary
course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the
issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete
and correct.
Dated: June 18, 2021
|
DISCOVER GROWTH FUND, LLC
|
|
|
|
/s/ John Kirkland
|
|
Name: John Kirkland, President of G.P. of Member
|
5
OWC Pharmaceuticals Rese... (CE) (USOTC:OWCP)
Historical Stock Chart
From Dec 2024 to Jan 2025
OWC Pharmaceuticals Rese... (CE) (USOTC:OWCP)
Historical Stock Chart
From Jan 2024 to Jan 2025